The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

Amid fresh surge in Covid-19 cases, a team of US researchers has developed a new type of mRNA vaccine that is more scalable and adaptable to tackle continuously evolving viruses such as SARS-CoV-2 ...

Moderna MRNA announced that it has submitted a regulatory filing with the FDA seeking approval for an updated version of its COVID-19 vaccine Spikevax, designed to target the LP.8.1 variant of the ...

Although the mRNA-1273 COVID-19 vaccine shows initially strong vaccine effectiveness (VE) against symptomatic infection and hospitalization in infants and young children, insight into its long-term VE ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

The mRNA-1273.825 vaccine, which targets the XBB.1.5 sublineage, was approved by the Food and Drug Administration (FDA) in September of 2023. The primary outcome was COVID-19-related hospitalization, ...

An ongoing challenge is that there continues to be widespread misinformation about the COVID-19 vaccine, a messenger ribonucleic acid (mRNA) vaccine that has been proven to be both safe and effective.